Skip to main content

Business

Physicians' Perceptions of Reimbursement as a Barrier to Comprehensive Diabetes Care

Alyssa Pozniak, PhD, Lois Olinger, MA, Victoria Shier, MA

Stakeholder Perspective

Diabetes Management Strategies: More Money Does Not Equal Better Care

by Gary M. Owens, MD

Health Plan Retention and Pharmacy Costs of Newly Diagnosed Patients with Chronic Kidney Disease in a Managed Care Population

Maureen Kubacki, PharmD, MBA , Chureen Carter, PharmD, MS , Alan D. L. Herrera, PharmD, Jim Wang, PhD, Janice M.S. Lopez, PharmD, MPH, Catherine T. Piech, MBA

Stakeholder Perspective

Alignment of Incentives along the Healthcare Payer Continuum for Patients with Kidney Disease

by Jeff Januska, PharmD

Impact of Prescription Benefit Coverage Limits on Sevelamer Hydrochloride Adherence for Patients with ESRD

Bharati Bhardwaja, PharmD, BCPS, Nikki Carroll, MS, Eli Korner, PharmD, Kavita V. Nair, PhD

Stakeholder Perspective

Balancing Horizontal and Vertical Equity within Managed Health Plans Drug Benefit

by Jack E. Fincham, PhD, RPh

Private Health Plans Perspectives: Electronic Personal Health Records and Electronic Prescribing

Nancy M. McGee, JD, MPH, Gene Reeder, RPh, PhD, Timothy S. Regan, BPharm, RPh, CPh, J.D. Kleinke, Steve Arnold, MD, MS, MBA, CPE

Stakeholder Perspective

Electronic PHRs and e-Prescribing: Not Quite There Yet

by Gary M. Owens, MD

Health Benefit Coverage, Reimbursement, and Influences on Traditional Pharmaceutical Channels

F. Randy Vogenberg, PhD, FASHP

Stakeholder Perspective

The Many Challenges of Pay-for-Performance Programs

by Gary M. Owens, MD

Impact of Etanercept Treatment on Absenteeism and Productivity: The Work Loss and Productivity Survey

Denise Globe, PhD, Peter Mazonson, MD, MBA, Chris Santas, MBA, Regina Murphy, MBA, Annie Cheng, Xingyue Huang, PhD, Arthur Kavanaugh, MD

Stakeholder Perspective

What Is the Value of Specialty Pharmaceuticals?

13
14
15
16

Page 16 of 16
Results 151 - 156 of 156